IC30
The SMART India Study -Take Home Points and Practical Implications.
Dr. Sheena Liz Mani
6 Talks
Abstract
Diabetic retinopathy (DR),a microvascular ocular sight-threatening complication of diabetes is one of the causes of preventable blindness if timely managed. Most literature on Diabetic Retinopathy are derived from the Western world. The results of landmark clinical trials are extrapolated to the Indian context and is the basis of preferred practice patterns in India. With a global prevalence of over 537 million people with diabetes, India is home to over 100 million , and it is important to understand the Indian picture and the burden on the Indian health care systems. While there are earlier publications on DR in India, the SMART India study was the first population based prospective study with pan-India representation. Given the magnitude of the problem, the need to understand the challenges is vital. This IC will walk you through the published results of the SMART India study and National prevalence of DR and blindness in known and unknown diabetes and economic implications.
Talks
Dr. Sheena Liz Mani 5.Artificial Intelligence in diabetic retinopathy screening and diagnosis
10 minutes
Dr. Thomas Cherian Sight-threatening DR and the need for risk based stratified screening. Do blood tests help?
9 minutes
Dr. Juhy Cherian 1.Smart India-Protocol and Study Design
6 minutes
Dr. R Rajalaksmi Burden of undiagnosed and sub-optimally controlled diabetes across India
9 minutes
Dr. Mahesh G National prevalance of DR and blindness in known & unknown diabetes and economic implications
10 minutes
Dr. Rajalaksmi Take home points
9 minutes